Inimmune to Present Key Updates at the 2025 World Vaccine Congress in Washington, DC April 21-24
Missoula, MT, April 15, 2025 – Inimmune, a clinical-stage biotechnology company specializing in next generation vaccine adjuvants, immunotherapies, and delivery systems, is excited to announce its participation in the 2025 World Vaccine Congress, taking place April 21–24 in Washington, DC. The company will share exciting progress from its clinical-stage immunotherapy and vaccine programs, and take […]
